Browse by Research Center

Baar, Joseph and Storkus, Walter J and Finke, James and Butterfield, Lisa and Lazarus, Hillard and Reese, Jane and Downes, Katharine and Budd, Thomas and Brufsky, Adam and Fu, Pingfu (2015) Pilot trial of a type I - polarized autologous dendritic cell vaccine incorporating tumor blood vessel antigen-derived peptides in patients with metastatic breast cancer. Journal for ImmunoTherapy of Cancer, 3 (S1).

Bancks, MP and Odegaard, AO and Koh, WP and Yuan, JM and Gross, MD and Pereira, MA (2015) Glycated hemoglobin and incident type 2 diabetes in singaporean Chinese adults: The Singapore Chinese Health Study. PLoS ONE, 10 (3).

Beumer, JH and Fu, KY and Anyang, BN and Siegfried, JM and Bakkenist, CJ (2015) Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma. BMC Cancer, 15 (1).

Chapman, BV and Wald, AI and Akhtar, P and Munko, AC and Xu, J and Gibson, SP and Grandis, JR and Ferris, RL and Khan, SA (2015) MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer, 15 (1).

Concha-Benavente, Fernando and Srivastava, Raghvendra M and Kansy, Benjamin and Ferris, Robert L (2015) PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer. Journal for ImmunoTherapy of Cancer, 3 (S2).

Davar, D and Socinski, MA and Dacic, S and Burns, TF (2015) Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinoma. Experimental Hematology and Oncology, 4 (1).

Eisermann, K and Dar, JA and Dong, J and Wang, D and Masoodi, KZ and Wang, Z (2015) Poly (A) binding protein cytoplasmic 1 is a novel co-regulator of the androgen receptor. PLoS ONE, 10 (7).

Ferris, Robert L and Even, Caroline and Haddad, Robert and Tahara, Makoto and Goswami, Trishna and Franks, April and Emeribe, Ugochi and Jarkowski, Anthony and Melillo, Giovanni and Licitra, Lisa (2015) Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle. Journal for ImmunoTherapy of Cancer, 3 (S2).

Geskin, A and Legowski, E and Chakka, A and Chandran, UR and Barmada, MM and LaFramboise, WA and Berg, J and Jacobson, RS (2015) Needs assessment for research use of high- throughput sequencing at a large academic medical center. PLoS ONE, 10 (6).

Goel, G and Sun, W (2015) Novel approaches in the management of pancreatic ductal adenocarcinoma: Potential promises for the future. Journal of Hematology and Oncology, 8 (1).

Greenberger, Joel and Kagan, Valerian and Bayir, Hulya and Wipf, Peter and Epperly, Michael (2015) Antioxidant Approaches to Management of Ionizing Irradiation Injury. Antioxidants, 4 (1). pp. 82-101. ISSN 2076-3921

Hecht, SS and Koh, WP and Wang, R and Chen, M and Carmella, SG and Murphy, SE and Yuan, JM (2015) Elevated levels of mercapturic acids of acrolein and crotonaldehyde in the urine of Chinese women in Singapore who regularly cook at home. PLoS ONE, 10 (3).

Hu, M and Wang, C and Li, W and Lu, W and Bai, Z and Qin, D and Yan, Q and Zhu, J and Krueger, BJ and Renne, R and Gao, SJ and Lu, C (2015) A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. PLoS Pathogens, 11 (9). ISSN 1553-7366

Hwang, BJ and Jin, J and Gao, Y and Shi, G and Madabushi, A and Yan, A and Guan, X and Zalzman, M and Nakajima, S and Lan, L and Lu, AL (2015) SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp. BMC Molecular Biology, 16 (1).

Kansy, Benjamin A and Lin, Yan and Ding, Fei and Gibson, Sandra Poveda and Jie, Hyun-Bae and Ferris, Robert L (2015) Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 3 (S2).

Kansy, Benjamin A and Srivastava, Raghvendra M and Jie, Hyun-Bae and Shayan, Gulidanna and Lei, Yu and Li, Jing and Gooding, William and Brandau, Sven and Lang, Stephan and Schmitt, Nicole and Freeman, Gordon J and Clump, David A and Ferris, Robert L (2015) Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model. Journal for ImmunoTherapy of Cancer, 3 (S2).

Lee, DH and Zhang, Y and Kassam, AB and Park, MJ and Gardner, P and Prevedello, D and Henry, S and Horbinski, C and Beumer, JH and Tawbi, H and Williams, BJ and Shaffrey, ME and Egorin, MJ and Abounader, R and Park, DM (2015) Combined PDGFR and HDAC inhibition overcomes PTEN disruption in Chordoma. PLoS ONE, 10 (8).

Li, J and Srivastava, RM and Ettyreddy, A and Ferris, RL (2015) Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients. Journal for ImmunoTherapy of Cancer, 3 (1).

Liao, S and Hartmaier, RJ and McGuire, KP and Puhalla, SL and Luthra, S and Chandran, UR and Ma, T and Bhargava, R and Modugno, F and Davidson, NE and Benz, S and Lee, AV and Tseng, GC and Oesterreich, S (2015) The molecular landscape of premenopausal breast cancer. Breast Cancer Research, 17 (1). ISSN 1465-5411

Liu, D and Sun, W and Hou, J and Yuan, R and Li, Z (2015) Pass quantity, focus on quality. Journal of Hematology and Oncology, 8 (1).

Logan, GJ and Dabbs, DJ and Lucas, PC and Jankowitz, RC and Brown, DD and Clark, BZ and Oesterreich, S and McAuliffe, PF (2015) Molecular drivers of lobular carcinoma in situ. Breast Cancer Research, 17 (1). ISSN 1465-5411

Long, Georgina V and Dummer, Reinhard and Ribas, Antoni and Puzanov, Igor and Michielin, Olivier and VanderWalde, Ari and Andtbacka, Robert HI and Cebon, Jonathan and Fernandez, Eugenio and Malvehy, Josep and Olszanski, Anthony J and Gajewski, Thomas F and Kirkwood, John M and Kuznetsova, Olga and Chen, Lisa and Kaufman, David R and Chou, Jeffrey and Hodi, F Stephen (2015) A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265). Journal for ImmunoTherapy of Cancer, 3 (S2).

Mehta, Kathan and Appleman, Leonard and Wang, Hong and Tarhini, Ahmad and Parikh, Rahul (2015) Impact of annual hospital volume of high dose interleukin-2 infusions on in-patient mortality in patients with melanoma and renal cell carcinoma. Journal for ImmunoTherapy of Cancer, 3 (S2).

Muthuswamy, R and Wang, L and Pitteroff, J and Gingrich, JR and Kalinski, P (2015) Combination of IFNα and poly-I: C reprograms bladder cancer microenvironment for enhanced CTL attraction. Journal for ImmunoTherapy of Cancer, 3 (1).

Pan, A and Teng, GG and Yuan, JM and Koh, WP (2015) Bidirectional association between self-reported hypertension and gout: The Singapore Chinese health study. PLoS ONE, 10 (10).

Pardee, AD and Yano, H and Weinstein, AM and Ponce, AAK and Ethridge, AD and Normolle, DP and Vujanovic, L and Mizejewski, GJ and Watkins, SC and Butterfield, LH (2015) Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer, 3 (1).

Perez, EA and Baehner, FL and Butler, SM and Thompson, EA and Dueck, AC and Jamshidian, F and Cherbavaz, D and Yoshizawa, C and Shak, S and Kaufman, PA and Davidson, NE and Gralow, J and Asmann, YW and Ballman, KV (2015) The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831. Breast Cancer Research, 17 (1). ISSN 1465-5411

Qu, Zhaoxia and Xiao, Gutian (2015) Identification and characterization of novel NF-kB dependent genes involved in HTLV-I pathogenesis. Retrovirology, 12 (S1).

Shu, Q and Lennemann, NJ and Sarkar, SN and Sadovsky, Y and Coyne, CB (2015) ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry. PLoS Pathogens, 11 (9). ISSN 1553-7366

Shuda, M and Guastafierro, A and Geng, X and Shuda, Y and Ostrowski, SM and Lukianov, S and Jenkins, FJ and Honda, K and Maricich, SM and Moore, PS and Chang, Y (2015) Merkel cell polyomavirus small t antigen induces cancer and embryonic merkel cell proliferation in a transgenic mouse model. PLoS ONE, 10 (11).

Srivastava, Raghvendra M and Clump, David A and Ferris, Robert L (2015) Anti-PD-1 mAb pre-radiotherapy (RT) loading dose and fractionated RT induce better tumor-specific immunity and tumor shrinkage than sequential administration in an HPV+ head and neck cancer model. Journal for ImmunoTherapy of Cancer, 3 (S2).

Sznol, Mario and Fishman, Mayer and Escudier, Bernard and McDermott, David F and Kluger, Harriet and Stadler, Walter M and Perez-Gracia, Jose and McNeel, Douglas G and Curti, Brendan D and Harrison, Michael R and Plimack, Elizabeth R and Appleman, Leonard and Fong, Lawrence and Drake, Charles G and Young, Tina C and Chasalow, Scott D and Ross-MacDonald, Petra and Simon, Jason S and Walker, Dana and Choueiri, Toni K (2015) Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. Journal for ImmunoTherapy of Cancer, 3 (S2).

Tarhini, AA and Lin, Y and Zahoor, H and Shuai, Y and Butterfield, LH and Ringquist, S and Gogas, H and Sander, C and Lee, S and Agarwala, SS and Kirwood, JM (2015) Pro-inflammatory cytokines predict relapse-free survival after one month of interferon-α but not observation in intermediate risk melanoma patients. PLoS ONE, 10 (7).

Tarhini, AA and Zahoor, H and Lin, Y and Malhotra, U and Sander, C and Butterfield, LH and Kirkwood, JM (2015) Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for ImmunoTherapy of Cancer, 3 (1).

Trivedi, Sumita and Srivastava, Raghvendra M and Concha-Benavente, Fernando and Garcia-Bates, Tatiana M and Li, Jing and Ferris, Robert L (2015) Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients. Journal for ImmunoTherapy of Cancer, 3 (S2).

Villaruz, LC and Huang, G and Romkes, M and Kirkwood, JM and Buch, SC and Nukui, T and Flaherty, KT and Lee, SJ and Wilson, MA and Nathanson, KL and Benos, PV and Tawbi, HA (2015) MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxelbased therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603. Clinical Epigenetics, 7 (1). ISSN 1868-7075

Vin-Raviv, N and Akinyemiju, TF and Galea, S and Bovbjerg, DH (2015) Depression and anxiety disorders among hospitalized women with breast cancer. PLoS ONE, 10 (6).

Vujanovic, Lazar and Stahl, Elizabeth and Pardee, Angela and Watkins, Simon and Gibson, Gregory and Butterfield, Lisa H (2015) Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability. Journal for ImmunoTherapy of Cancer, 3 (S2).

Wheeler, SE and Egloff, AM and Wang, L and James, CD and Hammerman, PS and Grandis, JR (2015) Challenges in EGFRvIII detection in head and neck squamous cell carcinoma. PLoS ONE, 10 (2).

Xu, L and Qu, YH and Chu, XD and Wang, R and Nelson, HH and Gao, YT and Yuan, JM (2015) Urinary levels of N-nitroso compounds in relation to risk of gastric cancer: Findings from the Shanghai cohort study. PLoS ONE, 10 (2).

Zarour, HM (2015) Targeting multiple inhibitory receptors to reverse melanoma-induced T cell dysfunction. Journal of Translational Medicine. 1 - 1.